ERNA vs SNPS · P/E 0.0, rev $582.0K vs P/E 63, rev $7.05B
Eterna Therapeutics Inc (ERNA) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported SNPS revenue for 2025-10-31 was $7.05B. Net income was $1.33B. Revenue was up 15.1% from 2024-10-31 to 2025-10-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the ERNA and SNPS stock pages for the full models.
Not investment advice.